These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 6021205)

  • 21. The chemistry of blood coagulation.
    Baugh RF; Hougie C
    Clin Haematol; 1979 Feb; 8(1):3-30. PubMed ID: 367664
    [No Abstract]   [Full Text] [Related]  

  • 22. [Synovial inflammation and coagulation factors. II. Biological study of synovial fluid in serogically positive rheumatoid arthritis].
    Soria C; Guérin B; Larrieu MJ; Caen J; Kahn MF; Girard ML
    Pathol Biol (Paris); 1972 Sep; 20(15):695-701. PubMed ID: 4116649
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood clotting defect in hibernating ground squirrels (Citellus tridecemlineatus).
    Lechler E; Penick GD
    Am J Physiol; 1963 Nov; 205(5):985-8. PubMed ID: 5877429
    [No Abstract]   [Full Text] [Related]  

  • 24. Congenital deficiency of Hageman factor (clotting factor XII). Report on the first two families found in Switzerland.
    Baumann R; Straub PW
    Helv Med Acta; 1968 Nov; 34(4):313-26. PubMed ID: 5704616
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity.
    Mina A; Favaloro EJ; Koutts J
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):203-7. PubMed ID: 22322136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Partial thromboplastin time. Change in time by alteration of the concentration of single blood coagulation factors using reagents from various producers. Effect of heparin on partial thromboplastin time].
    Averdunk R; Braun JS
    Blut; 1972 Jun; 24(6):372-81. PubMed ID: 5042320
    [No Abstract]   [Full Text] [Related]  

  • 27. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hageman factor (factor XII) deficiency in marine mammals.
    Robinson AJ; Kropatkin M; Aggeler PM
    Science; 1969 Dec; 166(3911):1420-2. PubMed ID: 5388978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic mechanisms in blood coagulation.
    Davie EW; Fujikawa K
    Annu Rev Biochem; 1975; 44():799-829. PubMed ID: 237463
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of factor VII on the assay of factor VIII by the one stage method using wettable surface.
    Altman R; Rouvier J; Reussi C
    Thromb Diath Haemorrh; 1972 Dec; 28(3):457-63. PubMed ID: 4675266
    [No Abstract]   [Full Text] [Related]  

  • 31. Preparation of 'contact product' as a reagent for coagulation tests.
    Pérez-Requejo JL; Ingram GI
    J Clin Pathol; 1975 Jul; 28(7):596-9. PubMed ID: 239026
    [No Abstract]   [Full Text] [Related]  

  • 32. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 33. Exchange transfusions with frozen blood. Effects on blood coagulation in the newborn.
    Kreuger A; Blombäck M
    Haemostasis; 1974; 3(5-6):329-39. PubMed ID: 4478768
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood coagulation: comparative studies in dogs, cats, horses and cattle.
    Osbaldiston GW; Stowe EC; Griffith PR
    Br Vet J; 1970 Oct; 126(10):512-21. PubMed ID: 5491587
    [No Abstract]   [Full Text] [Related]  

  • 35. Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood.
    Stief TW; Kurz J; Doss MO; Fareed J
    Thromb Res; 2000 Mar; 97(6):473-80. PubMed ID: 10704657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Congenital factor XIII deficiency: studies in an infant and his family].
    Mertner MF
    Monatsschr Kinderheilkd (1902); 1972 Jan; 120(1):28-31. PubMed ID: 5016722
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-heparin activity of lysosomal cationic proteins from polymorphonuclear leukocytes.
    Saba HI; Roberts HR; Herion JC
    Blood; 1968 Mar; 31(3):369-80. PubMed ID: 5640632
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelets and initiation of intrinsic clotting.
    Schiffman S; Rapaport SI; Chong MM
    Br J Haematol; 1973 May; 24(5):633-42. PubMed ID: 4712832
    [No Abstract]   [Full Text] [Related]  

  • 39. Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).
    Korsan-Bengtsen K
    Scand J Haematol; 1971; 8(5):359-68. PubMed ID: 4109186
    [No Abstract]   [Full Text] [Related]  

  • 40. Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma.
    Saito H; Ratnoff OD; Donaldson VH
    Circ Res; 1974 May; 34(5):641-51. PubMed ID: 4826936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.